TCG Crossover GP II, LLC 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-22 4:41 pm Purchase | 2024-11-15 | 13G | Dianthus Therapeutics, Inc. DNTH | TCG Crossover GP II, LLC | 1,501,624 5.100% | 1,501,624 (New Position) | Filing |